Plasma Biomarkers Associated with Clinical Outcomes of FOLFIRI Plus Ramucirumab in RAS Wild-Type Metastatic Colorectal Cancer: The JACCRO CC-16AR Trial

Yu Sunakawa, Hisateru Yasui, Manabu Shiozawa, Hiroyuki Takeda, Naoya Akazawa, Tamotsu Sagawa, Kazuhiro Shiraishi, Takahisa Kyogoku, Takashi Mine, Yasuhiro Yuasa, Takanori Watanabe, Tatsuya Kinjo, Yoshihiro Okita, Hiroyuki Okuyama, Satoshi Yuki, Koki Miyakawa, Ayana Kobara, Shoko Yanaka, Yukiko Abe, Wataru Ichikawa, Masashi Fujii, Akihito Tsuji

Open source

DOI: 10.1007/s11523-026-01223-2
Published: 2026-05-20
Container: Targeted Oncology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s11523-026-01223-2,
  title = {Plasma Biomarkers Associated with Clinical Outcomes of FOLFIRI Plus Ramucirumab in RAS Wild-Type Metastatic Colorectal Cancer: The JACCRO CC-16AR Trial},
  author = {Yu Sunakawa and Hisateru Yasui and Manabu Shiozawa and Hiroyuki Takeda and Naoya Akazawa and Tamotsu Sagawa and Kazuhiro Shiraishi and Takahisa Kyogoku and Takashi Mine and Yasuhiro Yuasa and Takanori Watanabe and Tatsuya Kinjo and Yoshihiro Okita and Hiroyuki Okuyama and Satoshi Yuki and Koki Miyakawa and Ayana Kobara and Shoko Yanaka and Yukiko Abe and Wataru Ichikawa and Masashi Fujii and Akihito Tsuji},
  year = {2026},
  journal = {Targeted Oncology},
  doi = {10.1007/s11523-026-01223-2},
  url = {https://doi.org/10.1007/s11523-026-01223-2}
}

RIS

TY  - JOUR
TI  - Plasma Biomarkers Associated with Clinical Outcomes of FOLFIRI Plus Ramucirumab in RAS Wild-Type Metastatic Colorectal Cancer: The JACCRO CC-16AR Trial
AU  - Yu Sunakawa
AU  - Hisateru Yasui
AU  - Manabu Shiozawa
AU  - Hiroyuki Takeda
AU  - Naoya Akazawa
AU  - Tamotsu Sagawa
AU  - Kazuhiro Shiraishi
AU  - Takahisa Kyogoku
AU  - Takashi Mine
AU  - Yasuhiro Yuasa
AU  - Takanori Watanabe
AU  - Tatsuya Kinjo
AU  - Yoshihiro Okita
AU  - Hiroyuki Okuyama
AU  - Satoshi Yuki
AU  - Koki Miyakawa
AU  - Ayana Kobara
AU  - Shoko Yanaka
AU  - Yukiko Abe
AU  - Wataru Ichikawa
AU  - Masashi Fujii
AU  - Akihito Tsuji
PY  - 2026
JO  - Targeted Oncology
DO  - 10.1007/s11523-026-01223-2
UR  - https://doi.org/10.1007/s11523-026-01223-2
ER  -

APA

Sunakawa, Y., Yasui, H., Shiozawa, M., Takeda, H., Akazawa, N., Sagawa, T., Shiraishi, K., Kyogoku, T., Mine, T., Yuasa, Y., Watanabe, T., Kinjo, T., Okita, Y., Okuyama, H., Yuki, S., Miyakawa, K., Kobara, A., Yanaka, S., Abe, Y., Ichikawa, W., Fujii, M., & Tsuji, A. (2026). Plasma Biomarkers Associated with Clinical Outcomes of FOLFIRI Plus Ramucirumab in RAS Wild-Type Metastatic Colorectal Cancer: The JACCRO CC-16AR Trial. Targeted Oncology. https://doi.org/10.1007/s11523-026-01223-2

Source records

crossref · retrieved 2026-09-26T21:43:49.497Z